-
1
-
-
0034648757
-
Thrombin signalling and protease-activated receptors
-
[Review]
-
Coughlin S.R. Thrombin signalling and protease-activated receptors. Nature 407 (2000) 258-264 [Review]
-
(2000)
Nature
, vol.407
, pp. 258-264
-
-
Coughlin, S.R.1
-
2
-
-
0035019636
-
Proteinase-activated receptors
-
[Review]
-
MacFarlane S.R., Seatter M.J., Kanke T., Hunter G.D., and Plevin R. Proteinase-activated receptors. Pharmacol Rev 53 (2001) 245-282 [Review]
-
(2001)
Pharmacol Rev
, vol.53
, pp. 245-282
-
-
MacFarlane, S.R.1
Seatter, M.J.2
Kanke, T.3
Hunter, G.D.4
Plevin, R.5
-
3
-
-
0034625055
-
Biphasic kinetics of activation and signaling for PAR1 and PAR4 thrombin receptors in platelets
-
Covic L., Gresser A.L., and Kuliopulos A. Biphasic kinetics of activation and signaling for PAR1 and PAR4 thrombin receptors in platelets. Biochemistry 39 (2000) 5458-5467
-
(2000)
Biochemistry
, vol.39
, pp. 5458-5467
-
-
Covic, L.1
Gresser, A.L.2
Kuliopulos, A.3
-
4
-
-
0026775223
-
Structure-function relationships in the activation of platelet thrombin receptors by receptor-derived peptides
-
Vassallo Jr. R.R., Kieber-Emmons T., Cichowski K., and Brass L.F. Structure-function relationships in the activation of platelet thrombin receptors by receptor-derived peptides. J Biol Chem 267 (1992) 6081-6085
-
(1992)
J Biol Chem
, vol.267
, pp. 6081-6085
-
-
Vassallo Jr., R.R.1
Kieber-Emmons, T.2
Cichowski, K.3
Brass, L.F.4
-
5
-
-
0032499696
-
Cloning and characterization of human protease-activated receptor 4
-
Xu W.F., Andersen H., Whitmore T.E., Presnell S.R., Yee D.P., Ching A., et al. Cloning and characterization of human protease-activated receptor 4. Proc Natl Acad Sci U S A 95 (1998) 6642-6646
-
(1998)
Proc Natl Acad Sci U S A
, vol.95
, pp. 6642-6646
-
-
Xu, W.F.1
Andersen, H.2
Whitmore, T.E.3
Presnell, S.R.4
Yee, D.P.5
Ching, A.6
-
6
-
-
0033862187
-
The antithrombotic effect of aprotinin: actions mediated via the protease-activated receptor 1
-
Poullis M., Manning R., Laffan M., Haskard D.O., Taylor K.M., and Landis R.C. The antithrombotic effect of aprotinin: actions mediated via the protease-activated receptor 1. J Thorac Cardiovasc Surg 120 (2000) 370-378
-
(2000)
J Thorac Cardiovasc Surg
, vol.120
, pp. 370-378
-
-
Poullis, M.1
Manning, R.2
Laffan, M.3
Haskard, D.O.4
Taylor, K.M.5
Landis, R.C.6
-
7
-
-
0029758276
-
Development of potent thrombin receptor antagonist peptides
-
Bernatowicz M.S., Klimas C.E., Hartl K.S., Peluso M., Allegretto N.J., and Seiler S.M. Development of potent thrombin receptor antagonist peptides. J Med Chem 39 (1996) 4879-4887
-
(1996)
J Med Chem
, vol.39
, pp. 4879-4887
-
-
Bernatowicz, M.S.1
Klimas, C.E.2
Hartl, K.S.3
Peluso, M.4
Allegretto, N.J.5
Seiler, S.M.6
-
8
-
-
0033404539
-
In vitro antiplatelet profile of FR171113, a novel non-peptide thrombin receptor antagonist
-
Kato Y., Kita Y., Nishio M., Hirasawa Y., Ito K., Yamanaka T., et al. In vitro antiplatelet profile of FR171113, a novel non-peptide thrombin receptor antagonist. Eur J Pharmacol 384 (1999) 197-202
-
(1999)
Eur J Pharmacol
, vol.384
, pp. 197-202
-
-
Kato, Y.1
Kita, Y.2
Nishio, M.3
Hirasawa, Y.4
Ito, K.5
Yamanaka, T.6
-
9
-
-
0034863348
-
Proteinase-activated receptor 4 (PAR4): activation and inhibition of rat platelet aggregation by PAR4-derived peptides
-
Hollenberg M.D., and Saifeddine M. Proteinase-activated receptor 4 (PAR4): activation and inhibition of rat platelet aggregation by PAR4-derived peptides. Can J Physiol Pharmacol 79 (2001) 439-442
-
(2001)
Can J Physiol Pharmacol
, vol.79
, pp. 439-442
-
-
Hollenberg, M.D.1
Saifeddine, M.2
-
10
-
-
0036285450
-
Selective inhibition of protease-activated receptor 4-dependent platelet activation by YD-3
-
Wu C.C., Hwang T.L., Liao C.H., Kuo S.C., Lee F.Y., Lee C.Y., et al. Selective inhibition of protease-activated receptor 4-dependent platelet activation by YD-3. Thromb Haemost 87 (2002) 1026-1033
-
(2002)
Thromb Haemost
, vol.87
, pp. 1026-1033
-
-
Wu, C.C.1
Hwang, T.L.2
Liao, C.H.3
Kuo, S.C.4
Lee, F.Y.5
Lee, C.Y.6
-
11
-
-
24944580749
-
Discovery of potent orally active thrombin receptor (protease activated receptor 1) antagonists as novel antithrombotic agents
-
Chackamannil S., Xia Y., Greenlee W.J., Clasby M., Doller D., Tsai H., et al. Discovery of potent orally active thrombin receptor (protease activated receptor 1) antagonists as novel antithrombotic agents. J Med Chem 48 (2005) 5884-5887
-
(2005)
J Med Chem
, vol.48
, pp. 5884-5887
-
-
Chackamannil, S.1
Xia, Y.2
Greenlee, W.J.3
Clasby, M.4
Doller, D.5
Tsai, H.6
-
12
-
-
0025309285
-
Primary pulmonary hypertension in a patient with a familial platelet storage pool disease: role of serotonin
-
Herve P., Drouet L., Dosquet C., Launay J.M., Rain B., Simonneau G., et al. Primary pulmonary hypertension in a patient with a familial platelet storage pool disease: role of serotonin. Am J Med 89 (1990) 117-120
-
(1990)
Am J Med
, vol.89
, pp. 117-120
-
-
Herve, P.1
Drouet, L.2
Dosquet, C.3
Launay, J.M.4
Rain, B.5
Simonneau, G.6
-
13
-
-
33646347663
-
Pathophysiological basis for anticoagulant and antithrombotic therapy in pulmonary hypertension
-
[Review]
-
Lopes A.A. Pathophysiological basis for anticoagulant and antithrombotic therapy in pulmonary hypertension. Cardiovasc Hematol Agents Med Chem 4 (2006) 53-59 [Review]
-
(2006)
Cardiovasc Hematol Agents Med Chem
, vol.4
, pp. 53-59
-
-
Lopes, A.A.1
-
14
-
-
33847415485
-
Pathology of pulmonary hypertension
-
Tuder R.M., Marecki J.C., Richter A., Fijalkowska I., and Flores S. Pathology of pulmonary hypertension. Clin Chest Med 28 (2007) 23-42
-
(2007)
Clin Chest Med
, vol.28
, pp. 23-42
-
-
Tuder, R.M.1
Marecki, J.C.2
Richter, A.3
Fijalkowska, I.4
Flores, S.5
-
15
-
-
4344571130
-
Soluble CD40 ligand in pulmonary arterial hypertension: possible pathogenic role of the interaction between platelets and endothelial cells
-
Damas J.K., Otterdal K., Yndestad A., Aass H., Solum N.O., Frøland S.S., et al. Soluble CD40 ligand in pulmonary arterial hypertension: possible pathogenic role of the interaction between platelets and endothelial cells. Circulation 110 (2004) 999-1005
-
(2004)
Circulation
, vol.110
, pp. 999-1005
-
-
Damas, J.K.1
Otterdal, K.2
Yndestad, A.3
Aass, H.4
Solum, N.O.5
Frøland, S.S.6
-
16
-
-
0024323159
-
Effect of intentional hemodilution on platelet survival in secondary pulmonary hypertension
-
Lopes A.A., Maeda N.Y., Ebaid M., Chamone D.F., and Pileggi F. Effect of intentional hemodilution on platelet survival in secondary pulmonary hypertension. Chest 95 (1989) 1207-1210
-
(1989)
Chest
, vol.95
, pp. 1207-1210
-
-
Lopes, A.A.1
Maeda, N.Y.2
Ebaid, M.3
Chamone, D.F.4
Pileggi, F.5
-
17
-
-
27544454099
-
Increased tyrosine phosphorylation of platelet proteins including pp125 (FAK) suggests endogenous activation and aggregation in pulmonary hypertension
-
Maeda N.Y., Bydlowski S.P., and Lopes A.A. Increased tyrosine phosphorylation of platelet proteins including pp125 (FAK) suggests endogenous activation and aggregation in pulmonary hypertension. Clin Appl Thromb Hemost 11 (2005) 411-415
-
(2005)
Clin Appl Thromb Hemost
, vol.11
, pp. 411-415
-
-
Maeda, N.Y.1
Bydlowski, S.P.2
Lopes, A.A.3
-
18
-
-
2942547753
-
Pulmonary arterial hypertension: epidemiology, pathobiology, assessment, and therapy
-
Galiè N., and Rubin L.J. Pulmonary arterial hypertension: epidemiology, pathobiology, assessment, and therapy. J Am Coll Cardiol 43(Suppl. S) (2004) 1S-90S
-
(2004)
J Am Coll Cardiol
, vol.43 SUPPL. S
-
-
Galiè, N.1
Rubin, L.J.2
-
19
-
-
0242438137
-
Regulation of protease-activated receptor 1 (PAR1) on platelets and responsiveness to thrombin receptor activating peptide (TRAP) during systemic inflammation in humans
-
Reiter R., Derhaschning U., Spiel A., Keen P., Cardona F., Mayr F., et al. Regulation of protease-activated receptor 1 (PAR1) on platelets and responsiveness to thrombin receptor activating peptide (TRAP) during systemic inflammation in humans. Thromb Haemost 90 (2003) 898-903
-
(2003)
Thromb Haemost
, vol.90
, pp. 898-903
-
-
Reiter, R.1
Derhaschning, U.2
Spiel, A.3
Keen, P.4
Cardona, F.5
Mayr, F.6
-
20
-
-
7544236615
-
Clinical inhibition of the seven-transmembrane thrombin receptor (PAR1) by intravenous aprotinin during cardiothoracic surgery
-
Day J.R.S., Punjabi P.P., Randi A.M., Haskard D.O., Landis R.C., and Taylor K.M. Clinical inhibition of the seven-transmembrane thrombin receptor (PAR1) by intravenous aprotinin during cardiothoracic surgery. Circulation 110 (2004) 2597-2600
-
(2004)
Circulation
, vol.110
, pp. 2597-2600
-
-
Day, J.R.S.1
Punjabi, P.P.2
Randi, A.M.3
Haskard, D.O.4
Landis, R.C.5
Taylor, K.M.6
-
21
-
-
0037296525
-
The role of platelet receptors and adhesion molecules in coronary artery disease
-
Samara W.M., and Gurbel P.A. The role of platelet receptors and adhesion molecules in coronary artery disease. Coron Artery Dis 14 (2003) 65-79
-
(2003)
Coron Artery Dis
, vol.14
, pp. 65-79
-
-
Samara, W.M.1
Gurbel, P.A.2
-
22
-
-
0031955060
-
Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease
-
Furman M.I., Benoit S.E., Barnard M.R., Valeri C.R., Borbone M.L., Becker R.C., et al. Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease. J Am Coll Cardiol 31 (1998) 352-358
-
(1998)
J Am Coll Cardiol
, vol.31
, pp. 352-358
-
-
Furman, M.I.1
Benoit, S.E.2
Barnard, M.R.3
Valeri, C.R.4
Borbone, M.L.5
Becker, R.C.6
-
23
-
-
0029973981
-
In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function
-
Michelson A.D., Barnard M.R., Hechtman H.B., MacGregor H., Connolly R.J., Loscalzo J., et al. In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function. Proc Natl Acad Sci U S A 93 (1996) 11877-11882
-
(1996)
Proc Natl Acad Sci U S A
, vol.93
, pp. 11877-11882
-
-
Michelson, A.D.1
Barnard, M.R.2
Hechtman, H.B.3
MacGregor, H.4
Connolly, R.J.5
Loscalzo, J.6
-
24
-
-
0035949524
-
Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin
-
Michelson A.D., Barnard M.R., Krueger L.A., Valeri C.R., and Furman M.I. Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin. Circulation 104 (2001) 1533-1537
-
(2001)
Circulation
, vol.104
, pp. 1533-1537
-
-
Michelson, A.D.1
Barnard, M.R.2
Krueger, L.A.3
Valeri, C.R.4
Furman, M.I.5
-
25
-
-
2142811498
-
Upregulation of the CD40/CD40 ligand dyad and platelet-monocyte aggregation in cigarette smokers
-
Harding S.A., Sarma J., Josephs D.H., Cruden N.L., Din J.N., Twomey P.J., et al. Upregulation of the CD40/CD40 ligand dyad and platelet-monocyte aggregation in cigarette smokers. Circulation 109 (2004) 1926-1929
-
(2004)
Circulation
, vol.109
, pp. 1926-1929
-
-
Harding, S.A.1
Sarma, J.2
Josephs, D.H.3
Cruden, N.L.4
Din, J.N.5
Twomey, P.J.6
-
26
-
-
41949116878
-
Circulating platelet-leukocyte aggregates: a marker of microvascular injury in diabetic patients
-
Elalamy I., Chakroun T., Gerotziafas G.T., Petropoulou A., Robert F., Karroum A., et al. Circulating platelet-leukocyte aggregates: a marker of microvascular injury in diabetic patients. Thromb Res 121 (2008) 843-848
-
(2008)
Thromb Res
, vol.121
, pp. 843-848
-
-
Elalamy, I.1
Chakroun, T.2
Gerotziafas, G.T.3
Petropoulou, A.4
Robert, F.5
Karroum, A.6
-
27
-
-
0035061393
-
Increased circulating platelet-leukocyte aggregates in myeloproliferative disorders is correlated to previous thrombosis, platelet activation and platelet count
-
Jensen M.K., Brown P.N., Lund B.V., Nielsen O.J., and Hasselbalch H.C. Increased circulating platelet-leukocyte aggregates in myeloproliferative disorders is correlated to previous thrombosis, platelet activation and platelet count. Eur J Haematol 66 (2001) 143-151
-
(2001)
Eur J Haematol
, vol.66
, pp. 143-151
-
-
Jensen, M.K.1
Brown, P.N.2
Lund, B.V.3
Nielsen, O.J.4
Hasselbalch, H.C.5
-
28
-
-
0037154270
-
Activation and inhibition of G protein-coupled receptors by cell-penetrating membrane-tethered peptides
-
Covic L., Gresser A.L., Talavera J., Swift S., and Kuliopulos A. Activation and inhibition of G protein-coupled receptors by cell-penetrating membrane-tethered peptides. Proc Natl Acad Sci U S A 99 (2002) 643-648
-
(2002)
Proc Natl Acad Sci U S A
, vol.99
, pp. 643-648
-
-
Covic, L.1
Gresser, A.L.2
Talavera, J.3
Swift, S.4
Kuliopulos, A.5
-
29
-
-
0021193273
-
Primary pulmonary hypertension: natural history and the importance of thrombosis
-
Fuster V., Steele P.M., Edwards W.D., Gersh B.J., McGoon M.D., and Frye R.L. Primary pulmonary hypertension: natural history and the importance of thrombosis. Circulation 70 (1984) 580-587
-
(1984)
Circulation
, vol.70
, pp. 580-587
-
-
Fuster, V.1
Steele, P.M.2
Edwards, W.D.3
Gersh, B.J.4
McGoon, M.D.5
Frye, R.L.6
|